P8A Stock Overview
An investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cordlife Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.15 |
| 52 Week High | S$0.32 |
| 52 Week Low | S$0.12 |
| Beta | 0.68 |
| 1 Month Change | -7.59% |
| 3 Month Change | -15.61% |
| 1 Year Change | -52.90% |
| 3 Year Change | -62.08% |
| 5 Year Change | -67.91% |
| Change since IPO | -78.53% |
Recent News & Updates
Recent updates
Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough
May 06
Risks Still Elevated At These Prices As Cordlife Group Limited (SGX:P8A) Shares Dive 31%
Mar 22Estimating The Fair Value Of Cordlife Group Limited (SGX:P8A)
Sep 07Cordlife Group (SGX:P8A) Will Be Hoping To Turn Its Returns On Capital Around
Aug 02Cordlife Group (SGX:P8A) Might Be Having Difficulty Using Its Capital Effectively
Apr 03Cordlife Group (SGX:P8A) Is Looking To Continue Growing Its Returns On Capital
Oct 15Cordlife Group's (SGX:P8A) Problems Go Beyond Weak Profit
Aug 22Shareholder Returns
| P8A | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | -6.4% | -1.9% | -1.3% |
| 1Y | -52.9% | -13.3% | 14.0% |
Return vs Industry: P8A underperformed the SG Healthcare industry which returned -13.3% over the past year.
Return vs Market: P8A underperformed the SG Market which returned 14% over the past year.
Price Volatility
| P8A volatility | |
|---|---|
| P8A Average Weekly Movement | 6.7% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in SG Market | 13.3% |
| 10% least volatile stocks in SG Market | 2.0% |
Stable Share Price: P8A has not had significant price volatility in the past 3 months compared to the SG market.
Volatility Over Time: P8A's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Ivan Yiu | www.cordlife.com |
Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. The company operates through two segments, Banking and Diagnostics. It offers cord blood, cord lining, and cord tissue banking services, including processing and storage of stem cells; and various diagnostics services, such as newborn genetic screening, pediatric vision and ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing, and newborn metabolic screening.
Cordlife Group Limited Fundamentals Summary
| P8A fundamental statistics | |
|---|---|
| Market cap | S$39.73m |
| Earnings (TTM) | -S$11.06m |
| Revenue (TTM) | S$36.61m |
1.0x
P/S Ratio-3.4x
P/E RatioIs P8A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| P8A income statement (TTM) | |
|---|---|
| Revenue | S$36.61m |
| Cost of Revenue | S$17.05m |
| Gross Profit | S$19.56m |
| Other Expenses | S$30.61m |
| Earnings | -S$11.06m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.043 |
| Gross Margin | 53.42% |
| Net Profit Margin | -30.21% |
| Debt/Equity Ratio | 0% |
How did P8A perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 11:31 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cordlife Group Limited is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Conrad Werner | Macquarie Research |
| John Cheong | Maybank Research Pte. Ltd. |
| Derrick Heng | Phillip Securities (HK) |